Jonathan Goodman, MPhil

Sexism and patriarchal views can prevent women from receiving equitable cancer care, according to researchers.

Researchers sought to determine whether acalabrutinib may lower the rate of treatment-related AEs while maintaining a similar PFS in patients with CLL.

Researchers sought to determine whether myeloablative consolidation after induction therapy would improve PFS in patients with newly diagnosed primary central nervous system lymphoma.

Researchers are conducting a randomized phase 3 trial evaluating the safety and efficacy of venetoclax with azacitidine among patients with previously untreated, higher-risk MDS.

Researchers sought to determine whether doublet therapy with dexamethasone and ixazomib would improve survival in patients with multiple myeloma compared with pomalidomide.

Researchers sought to determine whether patients with AML were being undertreated due to patient fear about side effects to treatment.

Researchers sought to determine whether enasidenib combined with azacitidine may increase survival in patients with IDH2-mutated myelodysplastic syndrome.

Researchers are running a phase 4 feasibility trial to determine the safety and effectiveness of at-home blinatumomab treatment in patients with MRD-positive B cell precursor ALL.

Researchers sought to determine whether first-line aspacytarabine would be safe and effective in patients with AML who cannot tolerate chemotherapy.

Researchers sought to determine whether giving maintenance ixazomib to patients with multiple myeloma who undergo allogeneic hematopoietic stem cell transplantation would have a clinical benefit.